Related references
Note: Only part of the references are listed.Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J. Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases
N. C. Turner et al.
ANNALS OF ONCOLOGY (2018)
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2018)
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt et al.
NATURE MEDICINE (2018)
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases
Neal Shah et al.
PHARMACOLOGICAL RESEARCH (2018)
Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer
Jean-David Fumet et al.
BMC CANCER (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial
Gabriel N. Hortobagyi
BREAST CANCER RESEARCH (2018)
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
A. Gonzalez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Attitudes Toward Family Involvement in Cancer Treatment Decision Making: The Perspectives of Patients, Family Caregivers, and Their Oncologists
Dong Wook Shin et al.
PSYCHO-ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Platinum-containing regimens for metastatic breast cancer
Sam J. Egger et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem
M. Cardona-Morrell et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences
Rebekah Laidsaar-Powell et al.
PATIENT EDUCATION AND COUNSELING (2016)
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
M. Piccart et al.
ANNALS OF ONCOLOGY (2014)
Impact of Timing and Setting of Palliative Care Referral on Quality of End-of-Life Care in Cancer Patients
David Hui et al.
CANCER (2014)
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
Camilla Zimmermann et al.
LANCET (2014)
Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System
Barry J. Laird et al.
CLINICAL CANCER RESEARCH (2013)
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
L. Staudacher et al.
ANNALS OF ONCOLOGY (2011)
Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study
Bridget Gwilliam et al.
BRITISH MEDICAL JOURNAL (2011)
Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer
Jennifer S. Temel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of a Palliative Care Intervention on Clinical Outcomes in Patients With Advanced Cancer The Project ENABLE II Randomized Controlled Trial
Marie Bakitas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Hepatic complications of breast cancer
Jennifer R. Diamond et al.
LANCET ONCOLOGY (2009)
Platinum-based chemotherapy in triple-negative breast cancer
B. Sirohi et al.
ANNALS OF ONCOLOGY (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer
Faruk Tas et al.
INVESTIGATIONAL NEW DRUGS (2008)
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
V Heinemann et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer - A north central cancer treatment group trial
PA Burch et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2005)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
M Vassilomanolakis et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
